[KRYS] QoQ Quarter Result on 31-Mar-2023 [#Q4]

Stock
[KRYS] Krystal Biotech, Inc.
Announcement Date
08-May-2023
Financial Year
2022
Quarter
31-Mar-2023 [#Q4]
Profit Trend
QoQ- -41.32%
YoY- 9.34%
Quarter Report
KRYS's Result
KRYS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 42,143 8,556 0 0 0 0 0 -
PBT 10,657 80,747 -33,210 -45,297 -32,052 -29,850 -28,108 -
Tax 1,965 -826 996 25,650 2,503 2,490 645 109.72%
NP 8,692 80,747 -33,210 -45,297 -32,052 -29,850 -28,108 -
Tax Rate -18.44% 1.02% - - - - - -
Total Cost 33,451 -72,191 33,210 45,297 32,052 29,850 28,108 12.26%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 20.63 943.75 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.31 2.88 -1.25 -1.76 -1.25 -1.17 -1.10 -
EPS Diluted 0.30 2.79 -1.25 -1.76 -1.25 -1.17 -1.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.